Results
|
121.
|
|
|
122.
|
|
|
123.
|
|
|
124.
|
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures. [electronic resource] by
- Xu, F J
- Yu, Y H
- Daly, L
- DeSombre, K
- Anselmino, L
- Hass, G M
- Berchuck, A
- Soper, J T
- Clarke-Pearson, D L
- Boyer, C
Producer: 19930826
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 11
Availability: No items available.
|
|
125.
|
|
|
126.
|
|
|
127.
|
|
|
128.
|
OVX1 as a marker for early stage endometrial carcinoma. [electronic resource] by
- Xu, F J
- Yu, Y H
- Daly, L
- Anselmino, L
- Hass, G M
- Berchuck, A
- Rodriguez, G C
- Soper, J T
- Clarke-Pearson, D L
- Hollis, D
Producer: 19940422
In:
Cancer vol. 73
Availability: No items available.
|
|
129.
|
|
|
130.
|
Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. [electronic resource] by
- Lukes, A S
- Kohler, M F
- Pieper, C F
- Kerns, B J
- Bentley, R
- Rodriguez, G C
- Soper, J T
- Clarke-Pearson, D L
- Bast, R C
- Berchuck, A
Producer: 19940601
In:
Cancer vol. 73
Availability: No items available.
|
|
131.
|
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. [electronic resource] by
- Alberts, D S
- Liu, P Y
- Hannigan, E V
- O'Toole, R
- Williams, S D
- Young, J A
- Franklin, E W
- Clarke-Pearson, D L
- Malviya, V K
- DuBeshter, B
Producer: 19970102
In:
The New England journal of medicine vol. 335
Availability: No items available.
|
|
132.
|
Elevation of multiple serum markers in patients with stage I ovarian cancer. [electronic resource] by
- Woolas, R P
- Xu, F J
- Jacobs, I J
- Yu, Y H
- Daly, L
- Berchuck, A
- Soper, J T
- Clarke-Pearson, D L
- Oram, D H
- Bast, R C
Producer: 19931119
In:
Journal of the National Cancer Institute vol. 85
Availability: No items available.
|
|
133.
|
Overexpression and mutation of p53 in epithelial ovarian cancer. [electronic resource] by
- Marks, J R
- Davidoff, A M
- Kerns, B J
- Humphrey, P A
- Pence, J C
- Dodge, R K
- Clarke-Pearson, D L
- Iglehart, J D
- Bast, R C
- Berchuck, A
Producer: 19910621
In:
Cancer research vol. 51
Availability: No items available.
|
|
134.
|
Overexpression and mutation of p53 in endometrial carcinoma. [electronic resource] by
- Kohler, M F
- Berchuck, A
- Davidoff, A M
- Humphrey, P A
- Dodge, R K
- Iglehart, J D
- Soper, J T
- Clarke-Pearson, D L
- Bast, R C
- Marks, J R
Producer: 19920409
In:
Cancer research vol. 52
Availability: No items available.
|
|
135.
|
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer. [electronic resource] by
- Clarke-Pearson, D L
- Van Le, L
- Iveson, T
- Whitney, C W
- Hanjani, P
- Kristensen, G
- Malfetano, J H
- Beckman, R A
- Ross, G A
- Lane, S R
- DeWitte, M H
- Fields, S Z
Producer: 20011011
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
136.
|
Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. [electronic resource] by
- Alvarez Secord, A
- Jones, E L
- Hahn, C A
- Petros, W P
- Yu, D
- Havrilesky, L J
- Soper, J T
- Berchuck, A
- Spasojevic, I
- Clarke-Pearson, D L
- Prosnitz, L R
- Dewhirst, M W
Producer: 20051108
In:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group vol. 21
Availability: No items available.
|